A. Iliadis

发表

An alternative method for the estimation of the terminal slope when a few data points are available.

A. Dokoumetzidis, P. Macheras, A. Iliadis, 1999, Journal of pharmaceutical sciences.

Non-linear kinetics of ethanol elimination in man: medico-legal applications of the terminal concentration-time data analysis.

A. Iliadis, R. Bruno, M. Treffot, 1983, Forensic science international.

Mathematical modeling of tumor growth and metastatic spreading: validation in tumor-bearing mice.

Athanassios Iliadis, Christian Faivre, Niklas Hartung, 2014, Cancer research.

Structural identifiability and sensitivity

A. Iliadis, 2019, Journal of Pharmacokinetics and Pharmacodynamics.

Oral Drug Absorption

P. Macheras, A. Iliadis, 2016 .

Physiologically based pharmacokinetic modeling of CYP3A4 induction by rifampicin in human: influence of time between substrate and inducer administration.

Athanassios Iliadis, Thierry Lavé, Guillaume Baneyx, 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Model-based assessment of erlotinib effect in vitro measured by real-time cell analysis

A. Walz, T. Lavé, A. Iliadis, 2015, Journal of Pharmacokinetics and Pharmacodynamics.

Evaluation of Bayesian estimation in comparison to NONMEM for population pharmacokinetic data analysis: Application to pefloxacin in intensive care unit patients

Alain Durand, Jaap W. Mandema, Bruno Lacarelle, 1992, Journal of Pharmacokinetics and Biopharmaceutics.

Kinetic Nomograms Assist Individualization of Drug Regimens

A. Iliadis, H. Marouani, Anastasios Zografidis, 2011, Clinical pharmacokinetics.

A reaction limited in vivo dissolution model for the study of drug absorption: Towards a new paradigm for the biopharmaceutic classification of drugs

G. Melagraki, P. Macheras, A. Iliadis, 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Comparative pharmacokinetics and metabolism of doxorubicin and epirubicin in patients with metastatic breast cancer.

P. Vrignaud, L. Mauriac, J. Robert, 1985, Cancer treatment reports.

Bayesian Estimation of Cyclosporine Clearance in Bone Marrow Graft

A Iliadis, J P Cano, A. Iliadis, 1990, Therapeutic drug monitoring.

[Dosage regimen optimization in cancer chemotherapy using a mathematical model].

Athanassios Iliadis, Joseph Ciccolini, Dominique Barbolosi, 2003, Bulletin du cancer.

L. Ouafik, B. Lacarelle, J. Seitz, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

STEADY-STATE DOSAGE REGIMEN CALCULATIONS IN LINEAR

A. Iliadis, 1986 .

Cytidine deaminase residual activity in serum is a predictive marker of early severe toxicities in adults after gemcitabine-based chemotherapies.

N. André, J. Seitz, A. Iliadis, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CDA deficiency as a possible culprit for life-threatening toxicities after cytarabine plus 6-mercaptopurine therapy: pharmacogenetic investigations.

N. André, L. Ouafik, B. Lacarelle, 2012, Pharmacogenomics.

Phase I trial and pharmacological study of a 3-hour paclitaxel infusion in children with refractory solid tumours: a SFOP study

D. Frappaz, G. Vassal, J. Arditti, 2001, British Journal of Cancer.

Tumor growth modeling from clinical trials reveals synergistic anticancer effect of the capecitabine and docetaxel combination in metastatic breast cancer

A. Iliadis, R. Bruno, N. Frances, 2011, Cancer Chemotherapy and Pharmacology.

Pharmacokinetics and metabolism of epirubicin during repetitive courses of administration in Hodgkin's patients.

P. Vrignaud, J. Robert, A. Iliadis, 1985, European journal of cancer & clinical oncology.

Time dependency of adriamycin and adriamycinol kinetics

A. Iliadis, J. Cano, A. Durand, 2004, Cancer Chemotherapy and Pharmacology.

Dosage predictions in high-dose methotrexate infusions. Part 1: Evaluation of the classic test-dose protocol.

A. Iliadis, R. Bruno, J. Cano, 1985, Cancer drug delivery.

In Vitro and In Vivo Evaluation of Lipofufol, a New Triple Stealth Liposomal Formulation of Modulated 5-Fu: Impact on Efficacy and Toxicity

A. Iliadis, J. Ciccolini, S. Mollard, 2013, Pharmaceutical Research.

Pharmacokinetics of flunitrazepam following single dose oral administration in liver disease patients compared with healthy volunteers

A. Iliadis, P. Coassolo, M. Antoni, 1990, Fundamental & clinical pharmacology.

Clinical pharmacokinetics of the antitumor drug navelbine (5'-noranhydrovinblastine).

J. Barbet, A. Iliadis, R. Rahmani, 1987, Cancer research.

Combination of thymidine phosphorylase gene transfer and deoxyinosine treatment greatly enhances 5-fluorouracil antitumor activity in vitro and in vivo.

P. Cuq, A. Iliadis, J. Ciccolini, 2001, Molecular cancer therapeutics.

Pharmacokinetics and pharmacodynamics of nitrosourea fotemustine: a French cancer centre multicentric study.

A Iliadis, G Milano, G. Milano, 1996, European journal of cancer.

Beta-lactamase levels and inducibility in sequential isolates of Pseudomonas aeruginosa from a patient undergoing ceftazidime therapy.

A. Iliadis, W. Nichols, S. Richards, 1989, The Journal of antimicrobial chemotherapy.

Comparison of simulated cumulative drug versus time data sets with indices.

A. Iliadis, C. Reppas, M. Vertzoni, 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Early severe toxicities after capecitabine intake: possible implication of a cytidine deaminase extensive metabolizer profile

A. Iliadis, J. Ciccolini, F. Duffaud, 2009, Cancer Chemotherapy and Pharmacology.

Biodistribution, Tumor Uptake and Efficacy of 5-FU-Loaded Liposomes: Why Size Matters

A. Iliadis, J. Ciccolini, S. Mollard, 2014, Pharmaceutical Research.

Ursodeoxycholic acid modulates cyclosporin A oral absorption in liver transplant recipients *

P. Macheras, A. Iliadis, A. Bourgeon, 2000, Fundamental & clinical pharmacology.

An interface model for dosage adjustment connects hematotoxicity to pharmacokinetics

A. Iliadis, A. Iliadis, G. Freyer, 2008, Journal of Pharmacokinetics and Pharmacodynamics.

Population pharmacokinetics of mitoxantrone performed by a NONMEM method.

A Iliadis, A. Iliadis, B Richard, 1989, Journal of pharmaceutical sciences.

Population pharmacokinetics of docetaxel during phase I studies using nonlinear mixed-effect modeling and nonparametric maximum-likelihood estimation

M. Aapro, M. Marty, A. Iliadis, 2004, Cancer Chemotherapy and Pharmacology.

Pharmacokinetics of isosorbide dinitrate and its mononitrate metabolites after intravenous infusion

A. Iliadis, Y. Francès, J. Cano, 1986, Journal of Pharmacokinetics and Biopharmaceutics.

Model-based assessment of erlotinib effect in vitro measured by real-time cell analysis

A. Walz, T. Lavé, A. Iliadis, 2015, Journal of Pharmacokinetics and Pharmacodynamics.

Steady state pharmacokinetics of conventional versus controlled-release carbamazepine in patients with epilepsy

P. Genton, A. Iliadis, C. Dravet, 1993, Epilepsy Research.

Bayesian estimation and prediction of clearance in high-dose methotrexate infusions

A. Iliadis, R. Bruno, R. Favre, 1985, Journal of Pharmacokinetics and Biopharmaceutics.

Biodistribution, Tumor Uptake and Efficacy of 5-FU-Loaded Liposomes: Why Size Matters

A. Iliadis, J. Ciccolini, S. Mollard, 2014, Pharmaceutical Research.

Positive interaction between lapatinib and capecitabine in human breast cancer models: study of molecular determinants

G. Milano, A. Iliadis, J. Fischel, 2012, Fundamental & clinical pharmacology.

Application of Bayesian estimation for the prediction of an appropriate dosage regimen of amikacin.

A Iliadis, J P Cano, A. Iliadis, 1989, Journal of pharmaceutical sciences.

Time dependency of adriamycin.

A. Iliadis, J. Cano, A. Durand, 1982, Bulletin du cancer.

Optimizing Drug Regimens in Cancer Chemotherapy by an Efficacy-Toxicity Mathematical Model

Dominique Barbolosi, Athanassios Iliadis, A. Iliadis, 2000, Comput. Biomed. Res..

Naproxen kinetics in synovial fluid of patients with osteoarthritis.

A. Iliadis, R. Bruno, J. Cano, 1988, British journal of clinical pharmacology.

High-dose methotrexate in adults with osteosarcoma: a population pharmacokinetics study and validation of a new limited sampling strategy

A. Iliadis, J. Ciccolini, F. Duffaud, 2008, Anti-cancer drugs.

Pharmacokinetic modeling of ethyl loflazepate (VictanR) and its main active metabolites

A. Iliadis, J. Cano, B. Ba, 2006, Annals of Biomedical Engineering.

EFFECT OF RENAL FAILURE ON THE PHARMACOKINETICS OF ETHYL LOFLAZEPATE (Victan®) IN MAN

A. Iliadis, J. Necciari, A. Durand, 1989, Fundamental & clinical pharmacology.

Modeling in Biopharmaceutics, Pharmacokinetics and Pharmacodynamics: Homogeneous and Heterogeneous Approaches

Panos Macheras, Athanassios Iliadis, P. Macheras, 2005 .

The heterogeneous course of drug transit through the body.

Panos Macheras, Athanassios Iliadis, Aristides Dokoumetzidis, 2004, Trends in pharmacological sciences.

APIS: a software for model identification, simulation and dosage regimen calculations in clinical and experimental pharmacokinetics.

A Iliadis, A C Brown, M L Huggins, 1992, Computer methods and programs in biomedicine.

Nonlinear Dynamics and Chaos Theory: Concepts and Applications Relevant to Pharmacodynamics

Panos Macheras, Athanassios Iliadis, Aristides Dokoumetzidis, 2001, Pharmaceutical Research.

Stochastic Compartmental Models

P. Macheras, A. Iliadis, 2016 .

Evolution of plasma acetate concentration during ethanol metabolism in man.

A. Iliadis, R. Bruno, M. Treffot, 1983, Forensic science international.

A limited sampling strategy for the study of pirarubicin pharmacokinetics in humans

A. Iliadis, F. Leca, D. Marchiset-Leca, 2004, Cancer Chemotherapy and Pharmacology.

[Pharmacokinetics in phase IV studies for the preview of a therapeutic protocol].

A. Iliadis, J. Cano, Y. Carcassonne, 1988, Bulletin du cancer.

Simultaneous modelling of mexiletine and hydroxy‐methyl‐mexiletine data after single‐ and multiple‐dose administration of a sustained‐release mexiletine formulation

A. Iliadis, R. Bruno, P. Djiane, 1992, Biopharmaceutics & drug disposition.

Pharmacokinetics of mitoxantrone in cancer patients treated by high-dose chemotherapy and autologous bone marrow transplantation.

D. Blaise, P. Viens, A. Iliadis, 1992, British Journal of Cancer.

Revisiting dosing regimen using PK/PD modeling: the MODEL1 phase I/II trial of docetaxel plus epirubicin in metastatic breast cancer patients

Athanassios Iliadis, Jérôme Guitton, Dominique Barbolosi, 2016, Breast Cancer Research and Treatment.

Revisiting Dosing Regimen Using Pharmacokinetic/Pharmacodynamic Mathematical Modeling: Densification and Intensification of Combination Cancer Therapy

Athanassios Iliadis, Joseph Ciccolini, Dominique Barbolosi, 2016, Clinical Pharmacokinetics.

A limited sampling procedure for estimating adriamycin pharmacokinetics in cancer patients.

A. Iliadis, G. Milano, A. Iliadis, 1989, British Journal of Cancer.

Optimizing Druggability through Liposomal Formulations: New Approaches to an Old Concept

A. Iliadis, J. Ciccolini, R. Fanciullino, 2012, ISRN pharmaceutics.

Calculation of Individual Dosage Regimen of Cytosine Arabinoside (Ara‐C) Based on Metabolite Levels in Leukemic Cells

A. Iliadis, Y. Barra, Y. Carcassonne, 1994, Therapeutic Drug Monitoring.

Orally Administered Drug Products: Dissolution Data Analysis with a View to In Vitro‚ÄìIn Vivo Correlation

A. Iliadis, C. Reppas, M. Vertzoni, 2005 .

In Vitro and In Vivo Evaluation of Lipofufol, a New Triple Stealth Liposomal Formulation of Modulated 5-Fu: Impact on Efficacy and Toxicity

A. Iliadis, J. Ciccolini, S. Mollard, 2013, Pharmaceutical Research.

Nonlinear dynamics in clinical pharmacology: the paradigm of cortisol secretion and suppression.

Panos Macheras, Athanassios Iliadis, Aristides Dokoumetzidis, 2002, British journal of clinical pharmacology.

New approach for accurate simulation of human pharmacokinetics in an in vitro pharmacodynamic model: application to ciprofloxacin.

M. Saux, A. Iliadis, M. Fourtillan, 2001, The Journal of antimicrobial chemotherapy.

A Stochastic Model Describes the Heterogeneous Pharmacokinetics of Cyclosporin

Panos Macheras, Athanassios Iliadis, Laurent Claret, 2001, Journal of Pharmacokinetics and Pharmacodynamics.

Fractal Volume of Drug Distribution: It Scales Proportionally to Body Mass

Panos Macheras, Athanassios Iliadis, Vangelis Karalis, 2001, Pharmaceutical Research.

Steady-state dosage regimen calculations in linear pharmacokinetics.

A Iliadis, R Bruno, J P Cano, 1986, International journal of bio-medical computing.

Optimizing drug regimens in cancer chemotherapy: a simulation study using a PK-PD model

Dominique Barbolosi, Athanassios Iliadis, A. Iliadis, 2001, Comput. Biol. Medicine.

Population pharmacokinetic analysis of 5-FU and 5-FDHU in colorectal cancer patients: search for biomarkers associated with gastro-intestinal toxicity.

R. Danesi, G. Bocci, B. Lacarelle, 2012, Current topics in medicinal chemistry.

Dynamical dosage regimen calculations in linear pharmacokinetics.

A Iliadis, R Bruno, J P Cano, 1988, Computers and biomedical research, an international journal.

Structural identifiability and sensitivity

A. Iliadis, 2019, Journal of Pharmacokinetics and Pharmacodynamics.

Mathematical modeling of tumor growth and metastatic spreading: validation in tumor-bearing mice.

A. Iliadis, J. Ciccolini, F. Hubert, 2014, Cancer research.

Deterministic Compartmental Models

Panos Macheras, Athanassios Iliadis, P. Macheras, 2016 .

Optimize administration protocol of capecitabine plus docetaxel combination in metastatic breast cancer patients.

A. Iliadis, N. Frances, H. Marouani, 2012, Current topics in medicinal chemistry.

Stochastic modelling for determining zooplankton abundance

J. Durbec, F. Carlotti, A. Iliadis, 2007 .

Non‐linear regression analysis with errors in both variables: estimation of co‐operative binding parameters

P. Macheras, A. Iliadis, G. Valsami, 2000, Biopharmaceutics & drug disposition.